Loading...
Back to narrative

Modernizing Nuclear Plants And SMR Advances Will Create Future Opportunities

MIR logo
MIR
AnalystConsensusTarget
Not Invested
Published 21 Mar 2025

Update shared on16 Sep 2025

Fair value Increased 2.92%
Previous
AnalystConsensusTarget's Fair Value
US$23.50
3.4% undervalued intrinsic discount
16 Sep
US$22.70
Loading
1Y
131.2%
7D
6.4%

The consensus analyst price target for Mirion Technologies has increased modestly, while both the discount rate and future P/E ratio remain virtually unchanged, resulting in a slightly higher fair value estimate of $23.50.


What's in the News


  • Mirion Technologies entered into a strategic partnership with Westinghouse Electric to provide digital Ex-core Nuclear Instrumentation Systems, modernizing legacy neutron flux monitoring for global PWR operators.
  • The company launched the Vital Platform, a unified software suite for nuclear power sites, enhancing data integration, regulatory compliance, and operational efficiency.
  • The Mirion Medical group introduced several new products and software solutions for radiopharma and radiation monitoring, including the Graves Phantom, InstadoseVUE Beta Dosimeter, ec2 Software Suite enhancements, and mobile radiation monitors.
  • Mirion was dropped from various Russell value indexes but subsequently added to the S&P 1000, S&P 600, S&P 600 Information Technology, and S&P Composite 1500 indexes.
  • The company raised its fiscal 2025 earnings guidance, projecting revenue growth of 7.0% to 9.0% and organic revenue growth of 5.0% to 7.0%, citing foreign exchange and acquisition tailwinds but lowering expectations for Labs & Research and Dosimetry end-markets.

Valuation Changes


Summary of Valuation Changes for Mirion Technologies

  • The Consensus Analyst Price Target has risen slightly from $22.83 to $23.50.
  • The Discount Rate for Mirion Technologies remained effectively unchanged, moving only marginally from 8.59% to 8.63%.
  • The Future P/E for Mirion Technologies remained effectively unchanged, moving only marginally from 61.71x to 61.88x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.